Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004561095 | SCV005047836 | uncertain significance | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2023-12-29 | criteria provided, single submitter | clinical testing | The p.Y747C variant (also known as c.2240A>G), located in coding exon 19 of the LZTR1 gene, results from an A to G substitution at nucleotide position 2240. The tyrosine at codon 747 is replaced by cysteine, an amino acid with highly dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV004573497 | SCV005060692 | uncertain significance | Schwannomatosis 2 | 2023-12-05 | criteria provided, single submitter | clinical testing |